BRISTOL-MYERS SQUIBB COMPANY Disposal Group, Including Discontinued Operation, Intangible Assets
BRISTOL-MYERS SQUIBB COMPANY (BMY) had Disposal Group, Including Discontinued Operation, Intangible Assets of $126.00 million as of 2015-09-30, per its 10-K filed 2016-02-12.
Discontinued › Balance Sheet › Assets › Disposal Group, Including Discontinued Operation, Assets
us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssets · last filed 2016-02-12
- 2015-09-30: Disposal Group, Including Discontinued Operation, Intangible Assets $126.00M.
- 2015-06-30: Disposal Group, Including Discontinued Operation, Intangible Assets $126.00M.
- 2014-12-31: Disposal Group, Including Discontinued Operation, Intangible Assets $52.00M.
| Period end | Disposal Group, Including Discontinued Operation, Intangible Assets |
|---|---|
| 2015-09-30 | $126.00M 10-K · filed 2016-02-12 |
| 2015-06-30 | $126.00M 10-Q · filed 2015-07-23 |
| 2014-12-31 | $52.00M 10-Q · filed 2015-10-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |